Novartis4d
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G)
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...
Novartis2d
Novartis Indonesia
Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Novartis works closely with healthcare professionals around the world to support ...
Novartis1d
Career Search
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.
Novartis1d
Buscar vagas
(高级）医药代表 /（资深）产品专员 Regulär (Außendienst), Full time Innovative Medicines China Kunming (Yunnan Province) março 11, 2025 (高级 ...
Novartis2d
Caută un job
Explorați mai jos oportunitățile de carieră la Novartis.
Novartis2d
Carrières zoeken
Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search. Medical Science Liaison Manager, RLT ...
Novartis2d
Procurar vagas
Marketing Director Regular, Full time Innovative Medicines China Shanghai (Shanghai) Março 13, 2025 ...
Novartis2d
Nové pracovní příležitosti
Prozkoumejte pracovní příležitosti ve společnosti Novartis v seznamu níže. Pro další pozice ve společnosti Novartis Gene Therapies (dříve AveXis) navštivte GTx Hledání práce. Medical Science Liaison ...